SEARCH

SEARCH BY CITATION

References

  • 1
    American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2010; 33: S62S69.
  • 2
    The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. J Diabetes Invest 2010; 1: 212228.
  • 3
    World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Available at http://http://www.who.int/entity/diabetes/publications/report-hba1c_2011.pdf last accessed 24 February 2011.
  • 4
    Prentice RL, Gloeckler LA. Regression analysis of grouped survival data with application to breast cancer data. Biometrics 1978; 34: 5767.
  • 5
    Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 31603167.
  • 6
    Kadowaki T, Haneda M, Tominaga M, Yamada N, Iwamoto Y, Tajima N et al. Report of the Japan Diabetes Society’s Committee on the Diagnostic Criteria for Diabetes Mellitus and Glucose Metabolism Disorder – a new category of fasting plasma glucose values: ‘high-normal’. J Japan Diab Soc 2008; 51: 281283.
  • 7
    Kato M, Noda M, Suga H, Matsumoto M, Kanazawa Y. Fasting plasma glucose and incidence of diabetes – implication for the threshold for impaired fasting glucose: results from the population-based Omiya MA Cohort Study. J Atheroscler Thromb 2009; 16: 857861.
  • 8
    Noda M, Kato M, Takahashi Y, Matsushita Y, Mizoue T, Inoue M et al. Fasting plasma glucose and 5-year incidence of diabetes in the JPHC diabetes study – suggestion for the threshold for impaired fasting glucose among Japanese. Endocr J 2010; 57: 629637.
  • 9
    Ito C, Maeda R, Ishida S, Sasaki H, Harada H. Correlation among fasting plasma glucose, two-hour plasma glucose levels in OGTT and HbA1c. Diabetes Res Clin Pract 2000; 50: 225230.
  • 10
    Mohan V, Vijayachandrika V, Gokulakrishnan K, Anjana RM, Ganesan A, Weber MB et al. A1C cut points to define various glucose intolerance groups in Asian Indians. Diabetes Care 2010; 33: 515519.
  • 11
    Zhang X, Gregg EW, Williamson DF, Barker LE, Thomas W, Bullard KM et al. A1C level and future risk of diabetes: a systematic review. Diabetes Care 2010; 33: 16651673.
  • 12
    Cederberg H, Saukkonen T, Laakso M, Jokelainen J, Harkonen P, Timonen M et al. Postchallenge glucose, A1C, and fasting glucose as predictors of type 2 diabetes and cardiovascular disease: a 10-year prospective cohort study. Diabetes Care 2010; 33: 20772083.
  • 13
    Lorenzo C, Wagenknecht LE, Hanley AJ, Rewers MJ, Karter AJ, Haffner SM. A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 2010; 33: 21042109.
  • 14
    Shimazaki T, Kadowaki T, Ohyama Y, Ohe K, Kubota K. Hemoglobin A1c (HbA1c) predicts future drug treatment for diabetes mellitus: a follow-up study using routine clinical data in a Japanese university hospital. Transl Res 2007; 149: 196204.
  • 15
    Inoue K, Matsumoto M, Kobayashi Y. The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers. Diabetes Res Clin Pract 2007; 77: 451458.
  • 16
    Sato KK, Hayashi T, Harita N, Yoneda T, Nakamura Y, Endo G et al. Combined measurement of fasting plasma glucose and A1C is effective for the prediction of type 2 diabetes: the Kansai Healthcare Study. Diabetes Care 2009; 32: 644646.
  • 17
    Mooy JM, Grootenhuis PA, de Vries H, Kostense PJ, Popp-Snijders C, Bouter LM et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 1996; 39: 298305.
  • 18
    Rohlfing C, Wiedmeyer HM, Little R, Grotz VL, Tennill A, England J et al. Biological variation of glycohemoglobin. Clin Chem 2002; 48: 11161118.
  • 19
    Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002; 48: 436472.
  • 20
    Schnedl WJ, Liebminger A, Roller RE, Lipp RW, Krejs GJ. Hemoglobin variants and determination of glycated hemoglobin (HbA1c). Diabetes Metab Res Rev 2001; 17: 9498.
  • 21
    Lahousen T, Hegenbarth K, Ille R, Lipp RW, Krause R, Little RR et al. Determination of glycated hemoglobin in patients with advanced liver disease. World J Gastroenterol 2004; 10: 22842286.